T2 Biosystems CS TTOO

$0.00 +0.00 (12.50%)

Valuation

Market cap
17,000
Revenue TTM
$7,190,000
Net income TTM
$-50,080,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-696.52%
Debt to equity
0.00

Trading

Volume
500
Avg volume
11,922
Day's range
$0.00 – $0.00
Shares out
18,760,000
Stochastic %K
7%
Beta
8.42
Analysts
—
Price target
$5.00

Price

Company profile

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.

Industry
Diagnostics & Research
Sector
Healthcare
Phone
781 761 4646
Website
https://investors.t2biosystems.com
Address
101 Hartwell Avenue, Lexington, United States

Latest news

No headlines yet.